Impact Factor
7.883
Call For Paper
Volume 12 Issue 07
July 2026
Download Paper Format
Copyright Form
Author(s)
Ajay Bhojane Dipak Ghodekar Vikas Kandekar Narendra Gowekar
Abstract
Firibastat Is The New First-in-class Centrally Acting Aminopeptidase A Inhibitor Prodrug. Pharmacologically, Firibastat Prevents The Conversion Of Angiotensin-II To Angiotensin-III, One Of The Main Effector Peptides Of The Brain Renin–angiotensin System
Keywords
Hypertension
Aminopeptidase
Stimulation
Quantum Genomics
Paper ID
IJSARTV8I654930
Publication Date
June 2, 2022
Research Area
Pharmaceutical Quality Assurance